Sonya Zabludoff

3.9k citations
46 papers · 3.0k · h-index 27

Impact in

    • Cancer, Hypoxia, and Metabolism
  • Oncology top 2%
    • Cancer-related Molecular Pathways
    • PARP inhibition in cancer therapy
    • Peptidase Inhibition and Analysis

Papers in

    • DNA Repair Mechanisms 13
    • Cancer therapeutics and mechanisms 9
    • Glutathione Transferases and Polymorphisms 5
    • Cancer-related Molecular Pathways 7
    • Peptidase Inhibition and Analysis 4

Sonya Zabludoff

46 papers receiving 2.9k citations

Peers

Sonya Zabludoff
Comparison fields: 5 of 111
  • Cancer Research 680
  • Oncology 1.2k
  • Molecular Biology 2.2k
  • Reproductive Medicine 188
  • Cell Biology 245
Replace Peter Mullen with:
Peter Mullen United Kingdom
Siniša Volarević Croatia
Eliana Beraldi Canada
Madalena Tarsounas United Kingdom
Marek Liyanage United States
J. Chuck Harrell United States
Simone Chevalier Canada
Haico van Attikum Netherlands
Leonard Buckbinder United States
Arkady Celeste United States
Sonya Zabludoff relative to Peter Mullen United Kingdom Peter Mullen's profile →
Citations per field
00.5×1.6×
Peter Mullen · 1×
Citations per year

Countries citing papers authored by Sonya Zabludoff

Since Specialization
Citations

This map shows the geographic impact of Sonya Zabludoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonya Zabludoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonya Zabludoff more than expected).

Fields of papers citing papers by Sonya Zabludoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonya Zabludoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonya Zabludoff. The network helps show where Sonya Zabludoff may publish in the future.

Co-authors

The 25 scholars most cited alongside Sonya Zabludoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sonya Zabludoff Line = papers co-authored together Sonya Zabludoff links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2004410
2 1999349
3 2008333
4 2010249
5 2014144
6 2008129
7 2003123
8 2010106
9 199188
10 201586
11 201273
12 200471
13 201068
14 201167
15 200153
16 201452
17 198848
18
Inhibitors of checkpoint kinases: from discovery to the clinic.
200745
19 199444
20 201738

About Sonya Zabludoff

Sonya Zabludoff is a scholar working on Molecular Biology, Oncology, Cancer Research, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 3.0k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (13 papers), Cancer therapeutics and mechanisms (9 papers), Cancer-related Molecular Pathways (7 papers), Sperm and Testicular Function (7 papers), MicroRNA in disease regulation (6 papers), Glutathione Transferases and Polymorphisms (5 papers), Peptidase Inhibition and Analysis (4 papers) and Synthesis and biological activity (4 papers). The work is most often cited by research in Cancer Research (680 citations), Oncology (1.2k citations), Molecular Biology (2.2k citations), Reproductive Medicine (188 citations) and Cell Biology (245 citations). Sonya Zabludoff has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Susan Ashwell, William W. Wright, Hong Xu, Dalia Cohen, Paul Kwon, H Chamberlin, Lidia Sambucetti, Kenneth W. Bair, Michael J. Eck and Meredith A. Morgan. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology and Cell Cycle.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact